Navigation Links
Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac

It has been proposed by Pharmac, to hold a meeting regarding extension of funding for the cancer drug Herceptin that would allow the provision of drug to women with early breast cancer. // Currently, funding can only be availed by patients with advanced breast cancer. Extension of the budget for the cancer from the existing $47 million to $77 million has been planned.

The company officials are much more bothered about the safety and efficacy of the anti-cancer drug that is being assessed, according to Dr Peter Moodie, Medical Director, Pharmac. He further stated that the company officials are being open minded about the issue and are really interested in the drug.

The authorization body, Medsafe is yet to approve the proposal of the Pharmac's Pharmacology Therapeutics Advisory Committee.

HER2 positive cancers, an aggressive form account for 30% of all breast cancers against which Herceptin has been shown to be effective. Although previous studies have been able to demonstrate a 46% improved survival rate in those who received the drug and a decreased recurrence rate, the cost constraint has limited widespread use of drug.

Libby Burgess, Chairwoman, Breast Cancer Advocacy Coalition is very hopeful that a lot of valuable lives can be saved by the investment. Most women in New Zealand face severe financial constraints to enable breast cancer treatment. In fact, some even go to the extent of mortgaging their house. Nearly 2500 women in New Zealand are being diagnosed with breast cancer every year.

Pharmac and Roche Products are locally supplying the anti-cancer drug in New Zealand. The pharmaceutical companies are closely working together to extend the available funding. A spokesman for Roche announced that the assessment process is being fast-tracked.


'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
Other Medicine News:Health News:Genoptix Announces Participation at the Cowen and Company 29th Annual Health Care Conference 2Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 2Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 3Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 4Health News:Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery 2Health News:Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery 3Health News:Trust Us, Kids ... We've Got You Covered 2Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 2Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 3Health News:Tess Daly Supports Hallmark's Breast Cancer Campaign 2Health News:Tess Daly Supports Hallmark's Breast Cancer Campaign 3
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 1Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 2Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 3Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 4Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois 60329 1Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois 60329 2Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois 60329 3VetsFirst Established by United Spinal Association 3A First and Only Organization to Offer Full Membership to All Disabled Veterans Their Dependents 60326 1VetsFirst Established by United Spinal Association 3A First and Only Organization to Offer Full Membership to All Disabled Veterans Their Dependents 60326 2